Based on information from the National Institute for Neurological Disorders and Stroke, this CPB is revised to state that plasmapheresis is considered medically necessary for glucocorticoid refractory neuromyelitis optica. This CPB is revised to state that plasmapheresis is considered experimental and investigational for idiopathic thrombocytopenic purpura.